Hit by the tsunami of recessionary economy causing sales to dip and growth rates forecasted to fall below historic levels, pharma drug companies have hit the panic button and are trying out different ways in their quest to survive.
Mergers & Acquisitions
Pfizer\'s acquisition of Wyeth for US$68 Billion is a striking example. The company has acted to safeguard itself, owing to the plummeting revenues from it\'s popular drug 'Lipitor' and several other products, which would soon be faced with expired patent protection.
But this is being seen as just the beginning of a whole wave of mergers to come by. Some other expected acquisitions are being speculated such as Roche buying out the remaining share of Genentech, Merck merging with Schering-Plough, a merger between Sanofi and Bristol-Myers Squibb, and more.
In fact the general expectation the big pharma companies are all set to taking over smaller player raised the hopes among small biotechnology companies
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment